رؤية السماء الطبية
About The Factory
|
|
|
UltraVision CLPL is a contact lens manufacturer, with headquarters in Leighton Buzzard, Bedfordshire, England. It ships products across the world.HistoryContact Lens Precision Laboratories (CLPL), wa s founded in Cambridge in 1967. J. Keith Lomas, who was the company’s managing director between 1996 and 2017, oversaw the acquisition of UltraVision in July 2003. Upon that acquisition, the company name was changed to the UltraVision CLPL group. UltraVision CLPL opened a research-and-development office in 2007. Based in Cambridge, this office has developed various types of contact-lens technologies, including freeform surface modelling, toric lens design, and wavefront technologies, as well as lenses for persons suffering from keratoconus and corneal trauma, KeraSoft. In April 2018 Contact Lens Precision Laboratories was acquired by SEED Co., Ltd. |
Awards
|
|
|
In 2001, UltraVision’s Spherical Aberration Management technology received the Award for Innovation in British Optics from the Worshipful Company of Spectacle Makers. In the same year, the company received a Technology Award from EFCLIN (the European Federation of Contact Lens Industry).
UltraVision CLPL has received The Queen’s Award for Enterprise: Innovation twice – first in 2006 for its Spherical Aberration Management and Wavefront technologies and again in April 2010 for KeraSoft, UltraVision’s patented contact lens for irregular corneas.
2001: Innovation in British Optics, The Worshipful Company of Spectacle Makers
2001: The EFCLIN Technology Award
2006: The Queen’s Award for Enterprise: Innovation
2010: The Queen’s Award for Enterprise: Innovation
Commendations
2011: Manufacturer of the Year Awards: Innovation and Design Award
Awarded for continuous innovation and design excellence in responding to industry pressures or trends and with a strong focus on customer and consumer needs.
Innovation & Licensing
In a world where computing power and other technologies are continually evolving, contact lenses are no different.
Here at UltraVision we are continually launching advanced lenses, thus a major part of our business is in research and development.
UltraVision celebrated the opening of a new R&D facility in Leighton Buzzard, UK.
‘Significant investment in R&D is key to our strategic intent to continue to bring innovative products to market and to offer further licensing opportunities to third party contact lens manufacturers worldwide’
– J Keith Lomas. Non-Executive Director.
UltraVision utilises the highest calibre:
- Research and Design Team
- State of the Art Equipment – Research and Manufacturing
- Patenting and IP defence
- Commercial Team



